Valuation: Sandu Pharmaceuticals Limited

Market Cap 353M 3.66M 3.26M 3.04M 2.77M 5.22M 5.27M 36.8M 14.26M 180M 13.76M 13.46M 579M P/E 2025
30.6x
P/E 2026 16.7x
Enterprise Value 289M 3M 2.66M 2.48M 2.26M 4.27M 4.31M 30.09M 11.66M 147M 11.25M 11.01M 473M EV / Sales 2025
0.67x
EV / Sales 2026 0.33x
Free-Float
34.42%
Yield 2025
1.63%
Yield 2026 3.28%
09-11 Sandu Pharmaceuticals Limited Approves Appointment of Neeti Madan Kapre as Non Executive Independent Director, Effective 11 July 2026 CI
09-11 Sandu Pharmaceuticals Limited Approves Re-Designation of Balram Viswanathan as Managing Director, Effective from 11 July 2026 CI
08-11 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
06-19 Sandu Pharmaceuticals Limited Announces Demise of Umesh Sandu, Member of Audit Committee and Stakeholders Relationship Committee CI
06-19 Sandu Pharmaceuticals Limited Announces the Demise of Umesh Sandu, Managing Director CI
05-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-05 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March 2026 CI
02-06 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-12 Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-30 Sandu Pharmaceuticals Limited Approves the Continuation of Shri Vijay Kajarakar as Chief Financial Officer CI
25-08-13 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-28 Sandu Pharmaceuticals Posts INR3.3 Million Profit in Fiscal Q4 MT
25-05-28 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, on or Before October 25, 2025 CI
1 day+0.91%
1 week-1.27%
Current month+0.91%
1 month-4.67%
3 months-11.66%
6 months+8.43%
Current year-2.40%
1 week 35.3
Extreme 35.3
37.8
1 month 35.2
Extreme 35.2
39.5
Current year 30
Extreme 30
50
1 year 30
Extreme 30
50
3 years 30
Extreme 30
85
5 years 30
Extreme 30
86
10 years 10.45
Extreme 10.45
86
Manager TitleAgeSince
Chief Executive Officer 58 2026-07-10
Director of Finance/CFO - 2024-03-29
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 62 2011-05-31
Chairman 58 2024-03-29
Director/Board Member 69 2023-08-13
Change 5-day change 1-year change 3-year change Capi.($)
+0.91%-1.27%-20.86%-50.70% 3.67M
-0.61%-3.30%+38.46%+112.77% 1,025B
-1.02%-5.41%+37.61%+64.39% 623B
+1.11%-0.87%+7.55%+76.32% 459B
+0.34%-2.49%+60.10%+40.17% 355B
-0.95%-4.87%+22.46%+38.03% 336B
-1.46%-2.20%+11.84%+23.94% 270B
-1.35%-4.27%-4.55%+6.92% 247B
-1.04%-0.74%+35.02%+49.96% 220B
-1.87%-3.31%+30.22%+93.14% 183B
Average -0.28%-1.83%+21.78%+45.49% 371.82B
Weighted average by Cap. -0.17%-2.11%+29.72%+68.31%

Financials

2025 2026
Net sales 672M 6.98M 6.2M 5.78M 5.27M 9.94M 10.04M 70.07M 27.16M 343M 26.19M 25.63M 1.1B 699M 7.26M 6.45M 6.02M 5.48M 10.35M 10.44M 72.93M 28.27M 357M 27.26M 26.67M 1.15B
Net income 15.52M 161K 143K 133K 122K 230K 232K 1.62M 627K 7.91M 605K 592K 25.44M 17.66M 183K 163K 152K 139K 261K 264K 1.84M 714K 9.01M 689K 674K 28.96M
Net Debt -21.76M -226K -201K -187K -171K -322K -325K -2.27M -879K -11.09M -848K -830K -35.67M -64.37M -668K -594K -554K -505K -952K -961K -6.71M -2.6M -32.82M -2.51M -2.45M -106M
Logo Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Employees
258
Date Price Change Volume
26-10-01 ₹36.53 +0.91% 619
26-09-30 ₹36.20 +1.00% 1,707
26-09-29 ₹35.84 -1.81% 1,265
26-09-28 ₹36.50 -1.35% 1,084
26-09-25 ₹37.00 0.00% 1,625
  1. Stock Market
  2. Stocks
  3. SANDUPHQ6 Stock